Document:

Exhibit
10.3

 

NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AND, IF THE COMPANY REQUESTS, AN OPINION SATISFACTORY TO
THE COMPANY TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY
BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

COMMON
STOCK PURCHASE WARRANT

 

TraQiQ
Inc.

 

	Warrant
    Shares: 496,552	Initial
    Exercise Date: September 17, 2021

 

 

THIS
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, EVERGREEN CAPITAL MANAGEMENT LLC,
or its assigns (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00
p.m., New York City Time, on September 17, 2026 (the “Termination Date”) but not thereafter, to subscribe for and
purchase from TraQiQ Inc., a California corporation (the “Company”), up to 496,552 shares (as subject to adjustment
hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant
shall be equal to the Exercise Price, as defined in Section 1(b).

 

This
Warrant is being issued pursuant to that certain Securities Purchase Agreement dated as of September 17, 2021 between the Holder and
the Company (the “Securities Purchase Agreement”). In addition to the terms defined elsewhere in this Warrant, capitalized
terms that are not otherwise defined herein have the meanings given to such terms in the Securities Purchase Agreement.

 

1.
Exercise.

 

(a)
Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office
or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on
the books of the Company) of a duly executed facsimile copy (or e-mail attachment) of the Notice of Exercise in the form annexed hereto
and within five (5) Trading Days of the date said Notice of Exercise is delivered to the Company, the Company shall have received payment
of the aggregate Exercise Price of the shares thereby purchased by wire transfer or cashier’s check drawn on a United States bank
or, if available, pursuant to the cashless exercise procedure specified in Section 1(c) below. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation within five (5) Trading Days of the date the final Notice of
Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant
Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount
equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within three (3) Business
Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of
the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available
for purchase hereunder at any given time may be less than the amount stated on the face hereof.

 

    	 

    	 

    

 

(b)
Exercise Price. The exercise price per share of the Common Stock under this Warrant shall initially be $1.45, subject to adjustment
hereunder (the “Exercise Price”).

 

(c)
Cashless Exercise. If at any time after the six-month anniversary of the Initial Exercise Date, there is no effective Registration
Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant may
only be exercised, in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled
to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

	 	A
    =	the
    VWAP on the Trading Day immediately preceding the date on which Holder elects to exercise this Warrant by means of a “cashless
    exercise,” as set forth in the applicable Notice of Exercise;
	 	 	 
	 	B
    =	the
    Exercise Price of this Warrant, as adjusted hereunder; and
	 	 	 
	 	X
    =	the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.

 

If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrants
being exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to take any position contrary to
this Section 2(c).

 

Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 1(c).

 

(d)
Mechanics of Exercise.

 

i.
Delivery of Warrant Shares Upon Exercise. Warrant Shares purchased hereunder shall be transmitted by the Transfer Agent to the
Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository Trust Company through
its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant in such system and either
(A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by
the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule
144, and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder
or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified
by the Holder in the Notice of Exercise by the date that is five (5) Trading Days after the delivery to the Company of the Notice of
Exercise (such date, the “Warrant Share Delivery Date”). The Warrant Shares shall be deemed to have been issued, and
Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such shares for all
purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise Price (or by cashless exercise,
if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 1(d)(vi) prior to the issuance of such shares,
having been paid.

 

    	2

    	 

    

 

ii.
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.

 

iii.
Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
1(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

iv.
Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to an exercise on
or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market
transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares that the Holder anticipated receiving upon such exercise (a “Buy-In”),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to
pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of
the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to
pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant
as required pursuant to the terms hereof.

 

v.
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.

 

    	3

    	 

    

 

vi.
Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

vii.
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.

 

(e)
Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder’s Affiliates), would beneficially own in excess of the
Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially
owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon
(i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii)
exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation,
any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 1(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 1(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in
the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which
portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 1(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer
Agent setting forth the number of shares of Common Stock outstanding. Upon the written request of a Holder, the Company shall within
two Trading Days confirm orally or in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number
of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company,
including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock
was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial
Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 1(e) shall
continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such
notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in
strict conformity with the terms of this Section 1(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

    	4

    	 

    

 

2.
Certain Adjustments.

 

(a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 2(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or reclassification.

 

(b)
Subsequent Equity Sales. If, at any time while this Warrant is outstanding, the Company sells or grants any option to purchase
or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or
other disposition), any Common Stock or Common Stock Equivalents entitling any Person to acquire shares of Common Stock at an effective
price per share that is lower than the then Exercise Price (such lower price, the “Base Exercise Price” and such issuances,
collectively, a “Dilutive Issuance”) (if the holder of the Common Stock or Common Stock Equivalents so issued shall
at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or
otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive
shares of Common Stock at an effective price per share that is lower than the then Exercise Price, such issuance shall be deemed to have
occurred for less than the Exercise Price on such date of the Dilutive Issuance), then the Exercise Price shall be reduced to equal the
Base Exercise Price. Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued. Notwithstanding
the foregoing, no adjustment will be made under this Section 2(b) in respect of an Exempt Issuance. The Company shall notify the Holder
in writing, no later than three (3) Trading Days following the issuance of any Common Stock or Common Stock Equivalents subject to this
Section 2(b) excluding for avoidance of doubt any Exempt Issuance, indicating therein the applicable issuance price, or applicable reset
price, exchange price, exercise price, conversion price and other pricing terms (such notice, the “Dilutive Issuance Notice”).
For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 2(b), upon the
occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Warrant Shares based upon the Base Exercise Price
on or after the date of such Dilutive Issuance, regardless of whether the Holder accurately refers to the Base Exercise Price in the
Notice of Exercise.

 

    	5

    	 

    

 

(c)
Subsequent Rights Offerings. Except for any Exempt Issuance, in addition to any adjustments pursuant to Section 2(a) and 2(b)
above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities
or other property pro rata to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then
the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder
could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided,
however, to the extent that the Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the
Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial
ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall
be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).

 

(d)
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”),
at any time after the issuance of this Warrant, then, in each such case, upon the exercise of this Warrant, the Holder shall be entitled
to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including
without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution,
or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation
in such Distribution (provided, however, to the extent that the Holder’s right to participate in any such Distribution
would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such
Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent)
and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

    	6

    	 

    

 

(e)
Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock,
(iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding
shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each
a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right
to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 1(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of
the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 1(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant and the other
Transaction Documents in accordance with the provisions of this Section 2(e) pursuant to written agreements in form and substance reasonably
satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at
the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written
instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise
of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an
exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value
of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of
shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior
to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon
the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after
the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the “Company”
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named
as the Company herein.

 

(f)
Calculations. All calculations under this Section 2 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 2, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

    	7

    	 

    

 

(g)
Notice to Holder.

 

i.
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 2, the Company
shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the
number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii.
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the
Warrant Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a
notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock
of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such
reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to mail such notice or any defect
therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice. To the
extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any
of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.
The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date
of the event triggering such notice except as may otherwise be expressly set forth herein.

 

3.
Transfer of Warrant.

 

(a)
Transferability. Subject to compliance with any applicable securities laws, the restrictions referred to in the legend on the
first page of this Warrant, and the conditions set forth in Section 3(d) hereof, this Warrant and all rights hereunder are transferable,
in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not
so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.

 

    	8

    	 

    

 

(b)
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 3(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the original Issue Date and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

(c)
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
“Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.

 

(d)
Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, make usual and customary representations as to investment intent to the Company and provide
an opinion of counsel satisfactory to the Company.

 

(e)
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.

 

4.
Miscellaneous.

 

(a)
No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in Section 1(d)(i), except as expressly set forth in Section
2.

 

(b)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.

 

(c)
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business
Day.

 

    	9

    	 

    

 

(d)
Authorized Shares.

 

i.
The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock
a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

ii.
Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant, and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

iii.
Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.

 

(e)
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the laws of the State of Delaware as they are applied to contracts executed, delivered and to be wholly performed
within the State of Delaware.

 

(f)
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and
if the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

(g)
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding the fact that
all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of
this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder. No waiver by the Holder of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed
by the Holder. No failure by the Holder to exercise, or delay in exercising, any rights, remedy, power or privilege arising from this
Warrant shall operate or be construed as a waiver thereof.

 

    	10

    	 

    

 

(h)
Notices. Any notice, request or other document required or permitted to be given or delivered to the either party to the other
shall be delivered in by recognized overnight courier, facsimile or email as follows:

 

If
to the Holder:

 

Evergreen
Capital Management LLC

156
West Saddle River Road

Saddle
River, NJ 07458

Attn:
Manager

Email:
jpazdro@ egcmllc.com

 

If
to the Company:

 

TraQiQ
Inc.

14205
SE 36th Street, Suite 100

Bellevue,
WA 98006

Attn:
Chief Executive Officer

Email:
ajay@traqiq.com

 

(i)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.

 

(j)
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.

 

(k)
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.

 

(l)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.

 

(m)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.

 

********************

 

[Signature
Page to Follow.]

 

    	11

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.

 

	 	TraQiQ
    Inc.
	 	 	 
	 	By:	 
	 	Name:
    	Ajay
    Sikka
	 	Title:
    	Chief
    Executive Officer

 

    	12

    	 

    

 

EXHIBIT
A

 

NOTICE
OF EXERCISE

 

TO:
TraQiQ Inc.

 

(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant, and tenders
herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2)
Payment shall take the form of (check applicable box):

 

[  ]
in lawful money of the United States; or

 

[  ]
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in Section 1(c),
to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in Section 1(c).

 

(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

__________________________________

 

The
Warrant Shares shall be delivered to the following DWAC Account Number:

 

__________________________________

__________________________________

__________________________________

 

(4)
Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.

 

	[SIGNATURE
    OF HOLDER]	 
	 	 
	 	 
	Name
    of Investing Entity:	 
	 	 
	 	 
	Signature
    of Authorized Signatory of Investing Entity:	 
	 	 
	 	 
	Name
    of Authorized Signatory	 
	 	 
	 	 
	Title
    of Authorized Signatory	 
	 	 
	 	 
	Date	 

 

    	 

    	 

    

 

EXHIBIT
B

 

ASSIGNMENT
FORM

 

(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

	Name:	 	 
	 		(Please Print)
	 	 	 
	Address:	 	 
	 		(Please Print) 
	 	 	 
	Dated:
    	_______________
    __, ______	 

 

	Holder’s
    Signature:	 	 
	 	 	 
	Holder’s
    Address:Exhibit
10.4

 

SECURITY
AGREEMENT

 

This
SECURITY AGREEMENT, dated as of September 17, 2021 (as amended, supplemented or otherwise modified from time to time in accordance with
the provisions hereof, this “Agreement”), made by and between TraQiQ Inc., a California corporation (the “Grantor”),
in favor of Evergreen Capital Management LLC, as collateral agent for the Noteholders of the Notes of the Grantor referred to below (the
“Secured Party”).

 

WHEREAS,
Grantor has issued its 10% OID Senior Secured Promissory Notes due June 17, 2022 (as amended, and together with any promissory note(s)
issued in exchange for or upon the transfer thereof, the “Notes”) pursuant to the Securities Purchase Agreement dated
as of September 17, 2021 (the “Purchase Agreement”) between the Grantor and the purchasers of the Notes that are parties
thereto (each a “Noteholder” and collectively, the “Noteholders”); and

 

WHEREAS,
it is a condition precedent to the purchase of the Note by the Noteholders that the Grantor execute and deliver this Agreement.

 

NOW,
THEREFORE, in consideration of the mutual covenants, terms and conditions set forth herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1.
Definitions.

 

(a)
Unless otherwise specified herein, all references to Sections and Schedules herein are to Sections and Schedules of this Agreement.

 

(b)
Unless otherwise defined herein, terms used herein that are defined in the UCC shall have the meanings assigned to them in the UCC. However,
if a term is defined in Article 9 of the UCC differently than in another Article of the UCC, the term has the meaning specified in Article
9.

 

(c)
For purposes of this Agreement, the following terms shall have the following meanings:

 

“Collateral”
has the meaning set forth in Section ‎2.

 

“Event
of Default” means the occurrence of any of the following events:

 

(a)
the occurrence of an Event of Default under, and as defined in, the Note;

 

(b)
any representation or warranty of Grantor in this Agreement shall prove to have been incorrect in any material respect when made;

 

(c)
the failure by Grantor to observe or perform any of its material obligations hereunder for five (5) days after delivery to Grantor of
notice of such failure by or on behalf of the Secured Party; or

 

(d)
if any provision of this Agreement shall at any time for any reason be declared to be null and void, or the validity or enforceability
thereof shall be contested by Grantor, or a proceeding shall be commenced by Grantor, or by any governmental authority having jurisdiction
over Grantor, seeking to establish the invalidity or unenforceability thereof, or Grantor shall deny that Grantor has any liability or
obligation purported to be created under this Agreement.

 

    	 

    	 

    

 

“First
Priority” means, with respect to any lien and security interest purported to be created in any Collateral pursuant to this
Agreement, such lien and security interest is the most senior lien to which such Collateral is subject.

 

“Proceeds”
means “proceeds” as such term is defined in section 9-102 of the UCC and, in any event, shall include, without limitation,
all dividends or other income from the Collateral, collections thereon or distributions with respect thereto.

 

“Secured
Obligations” has the meaning set forth in Section ‎3.

 

“UCC”
means the Uniform Commercial Code as in effect from time to time in the State of Delaware or, when the laws of any other state govern
the method or manner of the perfection or enforcement of any security interest in any of the Collateral, the Uniform Commercial Code
as in effect from time to time in such state.

 

2.
Grant of Security Interest. The Grantor hereby pledges and grants to the Secured Party, and upon Secured Party making proper filings
of UCC-1 financing statements, hereby creates a continuing First Priority lien and security interest in favor of the Secured Party, in
and to all of its right, title and interest in and to the following, wherever located, whether now existing or hereafter from time to
time arising or acquired (collectively, the “Collateral”):

 

(a)
the properties, assets, and rights of the Grantor described in Attachment 1 hereto, wherever located, whether the Grantor now
has or hereafter acquires an ownership or other interest or power to transfer; and

 

(b)
all Proceeds and products of each of the foregoing, all books and records relating to the foregoing, all supporting obligations related
thereto, and all accessions to, substitutions and replacements for, and rents, profits and products of, each of the foregoing, and any
and all Proceeds of any insurance, indemnity, warranty or guaranty payable to the Grantor from time to time with respect to any of the
foregoing, whether now or hereafter arising.

 

3.
Secured Obligations. The Collateral secures the due and prompt payment and performance of:

 

(a)
the obligations of the Grantor from time to time arising under the Notes, this Agreement or otherwise with respect to the due and prompt
payment of (i) the principal of and premium, if any, interest (including interest accruing during the pendency of any bankruptcy, insolvency,
receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding) and Mandatory Default Amount
(as defined in the Notes), if any, on the Notes when and as due, whether at maturity, by acceleration, upon one or more dates set for
prepayment or otherwise and (ii) all other monetary obligations, including fees, costs, attorneys’ fees and disbursements, reimbursement
obligations, contract causes of action, expenses and indemnities, whether primary, secondary, direct or indirect, absolute or contingent,
due or to become due, now existing or hereafter arising, fixed or otherwise (including monetary obligations incurred during the pendency
of any bankruptcy, insolvency, receivership or other similar proceeding, regardless of whether allowed or allowable in such proceeding),
of the Grantor under or in respect of the Notes and this Agreement; and

 

    	2

    	 

    

 

(b)
all other covenants, duties, debts, obligations and liabilities of any kind of the Grantor under or in respect of the Notes, this Agreement
or any other document made, delivered or given in connection with any of the foregoing, in each case whether evidenced by a note or other
writing, whether allowed in any bankruptcy, insolvency, receivership or other similar proceeding, whether arising from an extension of
credit, issuance of a letter of credit, acceptance, loan, guaranty, indemnification or otherwise, and whether primary, secondary, direct
or indirect, absolute or contingent, due or to become due, now existing or hereafter arising, fixed or otherwise (all such obligations,
covenants, duties, debts, liabilities, sums and expenses set forth in Section ‎3 being herein collectively called the
“Secured Obligations”).

 

4.
Perfection of Security Interest and Further Assurances.

 

(a)
The Grantor shall, from time to time, as may be required by the Secured Party with respect to all Collateral, promptly take all actions
as may be requested by the Secured Party or any Noteholder to perfect the security interest of the Secured Party in the Collateral, including,
without limitation, with respect to all Collateral over which control may be obtained within the meaning of sections 8-106, 9-104, 9-105,
9-106 and 9-107 of the UCC, as applicable, the Grantor shall promptly take all actions as may be requested from time to time by the Secured
Party or any Noteholder so that control of such Collateral is obtained and at all times held by the Secured Party. All of the foregoing
shall be at the sole cost and expense of the Grantor.

 

(b)
The Grantor hereby irrevocably authorizes the Secured Party at any time and from time to time to file in any relevant jurisdiction any
financing statements and amendments thereto that contain the information required by Article 9 of the UCC of each applicable jurisdiction
for the filing of any financing statement or amendment relating to the Collateral, including any financing or continuation statements
or other documents for the purpose of perfecting, confirming, continuing, enforcing or protecting the security interest granted by the
Grantor hereunder, without the signature of the Grantor where permitted by law, including the filing of a financing statement describing
the Collateral as all assets now owned or hereafter acquired by the Grantor, or words of similar effect. The Grantor agrees to provide
all information required by the Secured Party or any Noteholder pursuant to this Section promptly to the Secured Party or such Noteholder,
as the case may be, upon request.

 

(c)
If the Grantor shall at any time hold or acquire any certificated securities, promissory notes, tangible chattel paper, negotiable documents
or warehouse receipts relating to the Collateral, the Grantor shall promptly deliver the same to the Secured Party, accompanied by such
instruments of transfer or assignment duly executed in blank as the Secured Party may from time to time specify.

 

(d)
The Grantor agrees that at any time and from time to time, at the expense of the Grantor, the Grantor will promptly execute and deliver
all further instruments and documents, obtain such agreements from third parties, and take all further action, that may be necessary
or desirable, or that the Secured Party or any Noteholder may reasonably request, in order to create and/or maintain the validity, perfection
or priority of and protect any security interest granted or purported to be granted hereby or to enable the Secured Party to exercise
and enforce its rights and remedies hereunder or under any other agreement with respect to any Collateral.

 

5.
Representations and Warranties. The Grantor represents and warrants as follows:

 

(a)
It has previously delivered to the Secured Party and each Noteholder a certificate signed by the Grantor and entitled “Perfection
Certificate” (“Perfection Certificate”), and that: (i) the Grantor’s exact legal name is that indicated
on the Perfection Certificate and on the signature page hereof, (ii) the Grantor is an organization of the type, and is organized in
the jurisdiction, set forth in the Perfection Certificate, (iii) the Perfection Certificate accurately sets forth, the Grantor’s
place of business (or, if more than one, its chief executive office), (iv) all other information set forth on the Perfection Certificate
relating to the Grantor is accurate and complete and (v) there has been no change in any such information since the date on which the
Perfection Certificate was signed by the Grantor.

 

    	3

    	 

    

 

(b)
All information set forth on the Perfection Certificate relating to the Collateral is accurate and complete in all material respects
and there has been no change in any such information since the date on which the Perfection Certificate was signed by the Grantor.

 

(c)
The Collateral consisting of securities (if any) have been duly authorized and validly issued, and are fully paid and non-assessable
and subject to no options to purchase or similar rights. None of the Collateral constitutes, or is the proceeds of, (i) farm products,
(ii) as-extracted collateral, (iii) manufactured homes, (iv) health-care-insurance receivables, (v) timber to be cut, (vi) aircraft,
aircraft engines, satellites, ships or railroad rolling stock. None of the account debtors or other persons obligated on any of the Collateral
is a governmental authority covered by the Federal Assignment of Claims Act or like federal, state or local statute or rule in respect
of such Collateral. The Grantor has at all times operated its business in compliance with all applicable provisions of the federal Fair
Labor Standards Act, as amended, and with all applicable provisions of federal, state and local statutes and ordinances dealing with
the control, shipment, storage or disposal of hazardous materials or substances.

 

(d)
At the time the Collateral becomes subject to the lien and security interest created by this Agreement, the Grantor will be the sole,
direct, legal and beneficial owner thereof, free and clear of any lien, security interest, encumbrance, claim, option or right of others
except for the security interest created by this Agreement and any third party property rights.

 

(e)
Upon Secured Party making proper filings of UCC-1 financing statements, the pledge of the Collateral pursuant to this Agreement creates
a valid and perfected First Priority security interest in the Collateral securing the payment and performance when due of the Secured
Obligations.

 

(f)
Grantor has full power, authority and legal right to issue the Note and to pledge the Collateral pursuant to this Agreement.

 

(g)
This Agreement has been duly authorized, executed and delivered by the Grantor and constitutes a legal, valid and binding obligation
of the Grantor enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or
other similar laws affecting creditors’ rights generally and subject to equitable principles (regardless of whether enforcement
is sought in equity or at law).

 

(h)
No authorization, approval, or other action by, and no notice to or filing with, any governmental authority or regulatory body is required
for the issuing of the Notes by the Grantor and the pledge by the Grantor of the Collateral pursuant to this Agreement or for the execution
and delivery of this Agreement by the Grantor or the performance by the Grantor of its obligations thereunder.

 

(i)
No the execution and delivery of this Agreement by the Grantor and the performance by the Grantor of its obligations hereunder, will
not violate any provision of any applicable law or regulation or any order, judgment, writ, award or decree of any court, arbitrator
or governmental authority, domestic or foreign, applicable to the Grantor or any of its property, or the organizational or governing
documents of the Grantor or any agreement or instrument to which the Grantor is party or by which it or its property is bound.

 

(j)
The Grantor has taken all action required on its part for control (as defined in sections 8-106, 9-104, 9-105, 9-106 and 9-107 of the
UCC, as applicable) to have been obtained by the Secured Party over all Collateral with respect to which such control may be obtained
pursuant to the UCC. No person other than the Secured Party has control or possession of all or any part of the Collateral.

 

    	4

    	 

    

 

6.
Voting, Distributions and Receivables.

 

(a)
The Secured Party agrees that unless an Event of Default shall have occurred and be continuing, the Grantor may, to the extent the Grantor
has such right as a holder of the Collateral consisting of securities, other Equity Interests or indebtedness owed by any obligor, vote
and give consents, ratifications and waivers with respect thereto, except to the extent that, any such vote, consent, ratification or
waiver materially detracts from the value thereof as Collateral or is inconsistent with or result in any violation of any provision of
the Notes or this Agreement.

 

(b)
If any Event of Default shall have occurred and be continuing, the Secured Party may, or at the request and option of the Secured Party
the Grantor shall, notify account debtors and other persons obligated on any of the Collateral of the security interest of the Secured
Party in any account, chattel paper, general intangible, instrument or other Collateral and that payment thereof is to be made directly
to the Secured Party during the continuance of such Event of Default.

 

7.
Covenants. The Grantor covenants as follows:

 

(a)
The Grantor will not, without providing at least 30 days’ prior written notice to the Secured Party and each Noteholder, change
its legal name, identity, type of organization, jurisdiction of organization, corporate structure, location of its chief executive office
or its principal place of business or its organizational identification number. The Grantor will, prior to any change described in the
preceding sentence, take all actions reasonably requested by the Secured Party to maintain the perfection and priority of the Secured
Party’s security interest in the Collateral.

 

(b)
The Collateral, to the extent not delivered to the Secured Party pursuant to Section ‎4, will be kept at those locations
listed on the Perfection Certificate and the Grantor will not remove the Collateral from such locations without providing at least 30
days’ prior written notice to the Secured Party and each Noteholder. The Grantor will, prior to any change described in the preceding
sentence, take all actions reasonably required by the Secured Party to maintain the perfection and priority of the Secured Party’s
security interest in the Collateral.

 

(c)
The Grantor shall, at its own cost and expense, defend title to the Collateral and the First Priority lien and security interest of the
Secured Party therein against the claim of any person claiming against or through the Grantor and shall maintain and preserve such perfected
First Priority security interest for so long as this Agreement shall remain in effect.

 

(d)
Except in the ordinary course of business, the Grantor will not sell, offer to sell, dispose of, convey, assign or otherwise transfer,
grant any option with respect to, restrict, or grant, create, permit or suffer to exist any mortgage, pledge, lien, security interest,
option, right of first offer, encumbrance or other restriction or limitation of any nature whatsoever on, any of the Collateral or any
interest therein.

 

(e)
The Grantor will keep the Collateral in good order and repair, ordinary wear and tear excepted, and will not use the same in violation
of law or any policy of insurance thereon. The Grantor will permit the Secured Party or any Noteholder, or its designee, to inspect the
Collateral at any reasonable time, wherever located, provided the Secured Party or such Noteholder has provided the Grantor at least
two Business Days’ prior written notice of such inspection.

 

    	5

    	 

    

 

(f)
Except for amounts in good faith dispute, the Grantor will pay promptly when due all taxes, assessments, governmental charges, and levies
upon the Collateral or incurred in connection with the use or operation of the Collateral or incurred in connection with this Agreement.

 

(g)
The Grantor will continue to operate its business in compliance with all applicable provisions of the federal Fair Labor Standards Act,
as amended, and with all applicable provisions of federal, state and local statutes and ordinances dealing with the control, shipment,
storage or disposal of hazardous materials or substances.

 

8.
Secured Party Appointed Attorney-in-Fact. The Grantor hereby appoints the Secured Party the Grantor’s attorney-in-fact,
with full authority in the place and stead of the Grantor and in the name of the Grantor or otherwise, from time to time during the continuance
of an Event of Default in the Secured Party’s discretion to take any action and to execute any instrument which the Secured Party
may deem necessary or advisable to accomplish the purposes of this Agreement (but the Secured Party shall not be obligated to and shall
have no liability to the Grantor or any third party for failure to do so or take action). This appointment, being coupled with an interest,
shall be irrevocable during the continuance of an Event of Default. The Grantor hereby ratifies all that said attorneys shall lawfully
do or cause to be done by virtue hereof in accordance with this Agreement.

 

9.
Secured Party May Perform. If the Grantor fails to perform any obligation contained in this Agreement, the Secured Party may itself
perform, or cause performance of, such obligation, and the expenses of the Secured Party incurred in connection therewith shall be payable
by the Grantor; provided that the Secured Party shall not be required to perform or discharge any obligation of the Grantor.

 

10.
Reasonable Care. The Secured Party shall have no duty with respect to the care and preservation of the Collateral beyond the exercise
of reasonable care. The Secured Party shall be deemed to have exercised reasonable care in the custody and preservation of the Collateral
in its possession if the Collateral is accorded treatment substantially equal to that which the Secured Party accords its own property,
it being understood that the Secured Party shall not have any responsibility for (a) ascertaining or taking action with respect to any
claims, the nature or sufficiency of any payment or performance by any party under or pursuant to any agreement relating to the Collateral
or other matters relative to any Collateral, whether or not the Secured Party has or is deemed to have knowledge of such matters, or
(b) taking any necessary steps to preserve rights against any parties with respect to any Collateral. Nothing set forth in this Agreement,
nor the exercise by the Secured Party of any of the rights and remedies hereunder, shall relieve the Grantor from the performance of
any obligation on the Grantor’s part to be performed or observed in respect of any of the Collateral.

 

11.
Remedies Upon Default.

 

(a)
If any Event of Default shall have occurred and be continuing, the Secured Party, without any other notice to or demand upon the Grantor,
may assert all rights and remedies of a secured party under the UCC or other applicable law, including, without limitation, the right
to take possession of, hold, collect, sell, lease, deliver, grant options to purchase or otherwise retain, liquidate or dispose of all
or any portion of the Collateral. If notice prior to disposition of the Collateral or any portion thereof is necessary under applicable
law, written notice mailed to the Grantor at its notice address as provided in Section ‎15 hereof ten
days prior to the date of such disposition shall constitute reasonable notice. So long as the sale of the Collateral is made in a commercially
reasonable manner, the Secured Party may sell such Collateral on such terms and to such purchaser(s) as the Secured Party in its absolute
discretion may choose, without assuming any credit risk and without any obligation to advertise or give notice of any kind other than
that necessary under applicable law. Without precluding any other methods of sale, the sale of the Collateral or any portion thereof
shall have been made in a commercially reasonable manner if conducted in conformity with reasonable commercial practices of creditors
disposing of similar property. To the extent permitted by applicable law, the Grantor waives all claims, damages and demands it may acquire
against the Secured Party arising out of the exercise by it of any rights hereunder. The Grantor hereby waives and releases to the fullest
extent permitted by law any right or equity of redemption with respect to the Collateral, whether before or after sale hereunder, and
all rights, if any, of marshalling the Collateral and any other security for the Secured Obligations or otherwise. At any such sale,
unless prohibited by applicable law, the Secured Party or any custodian may bid for and purchase all or any part of the Collateral so
sold free from any such right or equity of redemption. Neither the Secured Party nor any custodian shall be liable for failure to collect
or realize upon any or all of the Collateral or for any delay in so doing, nor shall it be under any obligation to take any action whatsoever
with regard thereto. The Secured Party shall not be obligated to clean-up or otherwise prepare the Collateral for sale.

 

    	6

    	 

    

 

(b)
If any Event of Default shall have occurred and be continuing, all rights of the Grantor to exercise the voting and other consensual
rights it would otherwise be entitled to exercise pursuant to Section ‎6(a) shall immediately cease during
the continuance of such Event of Default, and all such rights shall thereupon become vested in the Secured Party during the continuance
of such Event of Default, which shall have the sole right to exercise such voting and other consensual rights and receive and hold such
dividends and other distributions as Collateral during the continuance of such Event of Default.

 

(c)
If any Event of Default shall have occurred and be continuing, any cash held by the Secured Party as Collateral and all cash Proceeds
received by the Secured Party in respect of any sale of, collection from, or other realization upon all or any part of the Collateral
shall be applied in whole or in part by the Secured Party to the payment of expenses incurred by the Secured Party in connection with
the foregoing or incidental to the care or safekeeping of any of the Collateral or in any way relating to the Collateral or the rights
of the Secured Party hereunder, including reasonable attorneys’ fees, and the balance of such proceeds shall be applied or set
off against all or any part of the Secured Obligations in such order as the Secured Party, acting at the direction of the Noteholders,
shall elect. Any surplus of such cash or cash Proceeds held by the Secured Party and remaining after payment in full of all the Secured
Obligations shall be paid over to the Grantor or to whomsoever may be lawfully entitled to receive such surplus. The Grantor shall remain
liable for any deficiency if such cash and the cash Proceeds of any sale or other realization of the Collateral are insufficient to pay
the Secured Obligations and the fees and other charges of any attorneys employed by the Secured Party to collect such deficiency.

 

(d)
If the Secured Party shall determine to exercise its rights to sell all or any of the Collateral pursuant to this Section, the Grantor
agrees that, upon request of the Secured Party, the Grantor will, at its own expense, do or cause to be done all such acts and things
as may be necessary to make such sale of the Collateral or any part thereof valid and binding and in compliance with applicable law.

 

12.
No Waiver and Cumulative Remedies. The Secured Party shall not by any act (except by a written instrument pursuant to Section
‎14), delay, indulgence, omission or otherwise be deemed to have waived any right or remedy hereunder or to
have acquiesced in any Event of Default. All rights and remedies herein provided are cumulative and are not exclusive of any rights or
remedies provided by law.

 

13.
Security Interest Absolute. The Grantor hereby waives demand, notice, protest, notice of acceptance of this Agreement, notice
of loans made, credit extended, Collateral received or delivered or other action taken in reliance hereon and all other demands and notices
of any description. All rights of the Secured Party and liens and security interests hereunder, and all Secured Obligations of the Grantor
hereunder, shall be absolute and unconditional irrespective of:

 

(a)
any illegality or lack of validity or enforceability of any Secured Obligation or any related agreement or instrument;

 

    	7

    	 

    

 

(b)
any change in the time, place or manner of payment of, or in any other term of, the Secured Obligations, or any rescission, waiver, amendment
or other modification of the Note or this Agreement or any other agreement, including any increase in the Secured Obligations resulting
from any extension of additional credit or otherwise;

 

(c)
any taking, exchange, substitution, release, impairment or non-perfection of any Collateral or any other collateral, or any taking, release,
impairment, amendment, waiver or other modification of any guaranty, for all or any of the Secured Obligations;

 

(d)
any manner of sale, disposition or application of proceeds of any Collateral or any other collateral or other assets to all or part of
the Secured Obligations;

 

(e)
any default, failure or delay, willful or otherwise, in the performance of the Secured Obligations;

 

(f)
any defense, set-off or counterclaim (other than a defense of payment or performance) that may at any time be available to, or be asserted
by, the Grantor against the Secured Party; or

 

(g)
any other circumstance (including, without limitation, any statute of limitations) or manner of administering the Note or any existence
of or reliance on any representation by the Secured Party that might vary the risk of the Grantor or otherwise operate as a defense available
to, or a legal or equitable discharge of, the Grantor or any other grantor, guarantor or surety.

 

14.
Amendments. None of the terms or provisions of this Agreement may be amended, modified, supplemented, terminated or waived, and
no consent to any departure by the Grantor therefrom shall be effective unless the same shall be in writing and signed by the Secured
Party, acting at the direction of the Noteholders, and the Grantor, and then such amendment, modification, supplement, waiver or consent
shall be effective only in the specific instance and for the specific purpose for which made or given.

 

15.
Addresses For Notices. All notices and other communications provided for in this Agreement shall be in writing and shall be given
in the manner and become effective as set forth in the Purchase Agreement, and addressed to the respective parties at their addresses
as specified on the signature pages hereof or as to either party at such other address as shall be designated by such party in a written
notice to each other party.

 

16.
Continuing Security Interest; Further Actions. Upon Secured Party making proper filings of UCC-1 financing statements, this Agreement
shall create a continuing First Priority lien and security interest in the Collateral and shall (a) subject to Section ‎17
remain in full force and effect until payment and performance in full of the Secured Obligations, (b) be binding upon the Grantor, its
successors and assigns, and (c) inure to the benefit of the Secured Party and its successors, transferees and assigns; provided that
the Grantor may not assign or otherwise transfer any of its rights or obligations under this Agreement without the prior written
consent of the Secured Party, given at the direction of the Noteholders. Without limiting the generality of the foregoing clause (c),
any assignee of the Secured Party’s interests in any agreement or document which includes all or any of the Secured Obligations
shall, upon assignment in accordance with the Note and other transaction documents, become vested with all the benefits granted to the
Secured Party herein with respect to such Secured Obligations.

 

17.
Termination; Release. On the date on which all Secured Obligations have been paid and performed in full, the Secured Party will,
at the request and sole expense of the Grantor, (a) duly assign, transfer and deliver to or at the direction of the Grantor (without
recourse and without any representation or warranty) such of the Collateral as may then remain in the possession of the Secured Party,
together with any monies at the time held by the Secured Party hereunder, and (b) execute and deliver to the Grantor a proper instrument
or instruments acknowledging the satisfaction and termination of this Agreement.

 

18.
Governing Law; Jurisdiction; Jury Trial. This Agreement and any claim, controversy, dispute or cause of action (whether in contract
or tort or otherwise) based upon, arising out of or relating to this and the transactions contemplated hereby shall be governed by, and
construed in accordance with, the laws of the State of Delaware. Grantor hereby irrevocably and unconditionally (i) agrees that any legal
action, suit or proceeding arising out of or relating to this Agreement may be brought in the courts of the State of Delaware or of the
United States of America for the District of Delaware and (ii) submits to the jurisdiction of any such court in any such action, suit
or proceeding. Final judgment against the Grantor in any action, suit or proceeding shall be conclusive and may be enforced in any other
jurisdiction by suit on the judgment. GRANTOR HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT
IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY RELATING TO THIS AGREEMENT OR THE NOTES OR THE TRANSACTIONS
CONTEMPLATED HEREBY OR THEREBY WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY.

 

19.
Counterparts. This Agreement and any amendments, waivers, consents or supplements hereto may be executed in counterparts (and
by different parties hereto in different counterparts), each of which shall constitute an original, but all taken together shall constitute
a single contract. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or in electronic (i.e., “pdf”
or “tif”) format shall be effective as delivery of a manually executed counterpart of this Agreement. This Agreement constitutes
the entire contract among the parties with respect to the subject matter hereof and supersede all previous agreements and understandings,
oral or written, with respect thereto.

 

[SIGNATURE
PAGE FOLLOWS]

 

    	8

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

 

	 	TraQiQ
    Inc., as Grantor
	 	 	 
	 	By:	      
	 	Name:
    	Ajay
    Sikka
	 	Title:
    	Chief
    Executive Officer

 

	 	Address
    for Notices:
	 	 
	 	14205
    SE 36th Street, Suite 100
	 	Bellevue,
    WA 98006

 

	 	EVERGREEN
    CAPITAL MANAGEMENT LLC, as Secured Party
	 	 	 
	 	By:	                         
	 	Name:
    	Jeff
    Pazdro
	 	Title:
    	Manager

 

	 	Address
    for Notices:    
	 	 
	 	156
    West Saddle River Road
	 	Saddle
    River, NJ 07458

 

    	9

    	 

    

 

ATTACHMENT
1

 

All
right, title, interest, claims and demands of the Grantor in and to the following property:

 

	 	1.	All
    Accounts;
	 	 	 
	 	2.	All
    Chattel Paper;
	 	 	 
	 	3.	All
    Deposit Accounts and cash;
	 	 	 
	 	4.	All
    Documents;
	 	 	 
	 	5.	All
    General Intangibles;
	 	 	 
	 	6.	All
    Goods;
	 	 	 
	 	7.	All
    Instruments;
	 	 	 
	 	8.	All
    Intellectual Property;
	 	 	 
	 	9.	All
    Inventory;
	 	 	 
	 	10.	All
    Investment Property;
	 	 	 
	 	11.	All
    Unencumbered Equipment; and
	 	 	 
	 	12.	All
    Letter-of-Credit Rights.

 

To
the extent not otherwise included, all Proceeds and products of any and all of the foregoing, and all accessions to, substitutions and
replacements for, and rents and profits of each of the foregoing.

 

All
capitalized terms used in this Attachment 1 and not otherwise defined herein, shall have the respective meanings given to such
terms in the Uniform Commercial Code of the State of Delaware as in effect from time to time.

 

The
term “Intellectual Property” means all intellectual and similar property of every kind and nature hereafter acquired or developed
by the Grantor, including inventions, designs, patents (whether registered or unregistered), copyrights (whether registered or unregistered),
trademarks (whether registered or unregistered), trade secrets, domain names, confidential or proprietary technical and business information,
know-how, methods, processes, drawings, specifications or other data or information and all memoranda, notes and records with respect
to any research and development, software and databases and all embodiments or fixations thereof whether in tangible or intangible form
or contained on magnetic media readable by machine together with all such magnetic media and related documentation, registrations and
franchises, and all additions, improvements and accessions to, and books and records describing or used in connection with, any of the
foregoing.

 

    	 

    	 

    

 

Schedule
A

 

PERFECTION
CERTIFICATE

 

Reference
is hereby made to that certain Security Agreement (the “Security Agreement”), dated as of September 17, 2021, made
by and among TraQiQ Inc., a California corporation (the “Grantor”), in favor of Evergreen Capital Management LLC,
as Secured Party (the “Secured Party”). Capitalized terms used but not defined herein have the meanings assigned to
them in the Security Agreement.

 

The
undersigned hereby certifies to the Secured Party:

 

	1.	Name.

 

	 	(a)	The
    exact legal name of the Grantor, as such name appears in its respective certificate of incorporation or any other formation or organizational
    document, is as follows:
	 	 	 
	 	 	TraQiQ,
    Inc.

 

	 	(b)	The
    following are any other legal names that the Grantor has had in the past four months, together with the date of the relevant change:
	 	 	 
	 	 	NONE

    

 

	 	(c)	The
    following are any other names (including trade names) used by the Grantor, or any other business or organization to which the Grantor
    became the successor by merger, consolidation, acquisition, change in form, nature or jurisdiction of organization or otherwise,
    now or at any time during the past four months:
	 	 	 
	 	 	NONE

    

 

	2.	Other
    Identifying Factors.

 

	 	(a)	Grantor
    is the type of entity below:
	 	 	 
	 	 	A
    corporation

 

	 	(b)	Grantor
    is a registered organization except to the extent disclosed below:
	 	 	 
	 	 	N/A

 

	 	(c)	The
    jurisdiction of organization or formation of Grantor is as follows:
	 	 	 
	 	 	California

 

	 	(d)	Except
    as set forth below, Grantor has not changed its jurisdiction of organization or formation at any time during the past four months:
	 	 	 
	 	 	N/A

 

    	A-1

    	 

    

 

	3.	Current
    Locations.

 

	 	(a)	The
    chief executive office of the Grantor is located at the following address:
	 	 	 
	 	 	14205
    SE 36th Street, Suite 100, Belleview, WA 98006
	 	 	 
	 	 	The
    following are all locations where the Grantor maintains any books or records relating to any of the Collateral consisting of accounts,
    instruments, chattel paper, general intangibles or goods:
	 	 	 
	 	 	14205
    SE 36th Street, Suite 100, Belleview, WA 98006

 

	4.	Intellectual
    Property.

 

	 	(a)	The
    following is a list of all the Grantor’s United States patents, patent licenses, trademarks and trademark licenses registered
    with the United States Patent and Trademark Office and all other patents, patent licenses, trademarks and trademark licenses, including
    the name of the registered owner and the registration number of each patent, patent license, trademark and trademark license owned
    by the Grantor:
	 	 	 
	 	 	The
    domain name www.traqiq.com and other domain names used in the operation of the Grantor’s business.

 

	 	(b)	The
    following is a list of all the Grantor’s United States copyrights and copyright licenses and all other copyrights and copyright
    licenses, including the name of the registered owner and the registration number of each registered copyright or copyright license
    owned by the Grantor:
	 	 	 
	 	 	None

 

	5.	Stock
    Ownership and Other Equity Interests.

 

	 	(a)	The
    following is a list of all of the authorized, and the issued and outstanding, stock, partnership interests, limited liability company
    membership interests or other equity interests of the Grantor, the record and beneficial owners of such stock, partnership interests,
    membership interests or other equity interests and whether such interests are certificated or non-certificated. Also set forth below
    is each equity investment of the Grantor that represents 50% or less of the equity of the entity in which such investment was made:
	 	 	 
	 	 	The
    Grantor is authorized to issue 300,000,000 shares of common stock and 10,000,000 shares of Series A preferred stock. A stockholder
    list has separately been delivered to the Secured Party. In addition, options & warrants to purchase an aggregate of 6,810,184
    shares of common stock of the Grantor are outstanding.

 

	6.	Instruments
    and Tangible Chattel Paper.

 

	 	(a)	The
    following is a list of all instruments (other than checks to be deposited in the ordinary course of business), promissory notes,
    tangible chattel paper and other evidence of indebtedness held by the Grantor:
	 	 	 
	 	 	None.

 

	7.	Schedule
    of Filings.

 

	 	(a)	The
    following is a list of the appropriate filing offices for the UCC-1 financing statements:
	 	 	 
	 	 	TraQiQ,
    Inc. – State of California, State of Washington

 

	 	(b)	The
    following is a list of the appropriate filing offices for the Intellectual Property filings described above:
	 	 	 
	 	 	State
    of California, State of Washington

    

 

[signature
page follows]

 

    	A-2

    	 

    

 

IN
WITNESS WHEREOF, the undersigned executed this certificate effective as of September 17, 2021.

 

	 	TraQiQ
    Inc.
	 	 	 
	 	By:	 
	 	Name:
    	Ajay
    Sikka
	 	Title:
    	Chief
    Executive Officer

 

    	A-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}]]